RUDMAN ERROL M - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 105 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RUDMAN ERROL M ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q2 2015$389,000
-94.2%
65,727
-89.6%
0.13%
-94.4%
Q1 2015$6,744,000
+139.4%
630,900
+110.3%
2.34%
+104.1%
Q4 2014$2,817,000
+266.8%
300,000
+200.0%
1.14%
+197.4%
Q3 2014$768,000100,0000.38%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2015
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders